Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03472274
Title Durvalumab (MEDI4736) and TREmelimumab in NEOadjuvant Bladder Cancer Patients (DUTRENEO) (DUTRENEO)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fundacion CRIS de Investigacion para Vencer el Cancer
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.